Clinical Trials
295 trialsNCT06937567 2026-05-26
CDH17 CAR-T Therapy in Advanced Malignant Solid Tumors
Zhejiang University
Phase EARLY_PHASE1 Recruiting
NCT04975217 2026-05-22
Fecal Microbial Transplants for the Treatment of Pancreatic Cancer
M.D. Anderson Cancer Center
Phase EARLY_PHASE1 Suspended
NCT05365893 2026-05-22
PHL Treatment in Pancreatic Cancer
Fox Chase Cancer Center
Phase EARLY_PHASE1 Active not recruiting
NCT03594630 2026-05-20
Active Surveillance and Chemotherapy Before Surgery in Treating Participants With Stage II-III Rectal Cancer
M.D. Anderson Cancer Center
Phase EARLY_PHASE1 Recruiting
NCT07595237 2026-05-19
A IIT Study of 177Lu-DOTA-SNA040
SmartNuclide Biopharma
Phase EARLY_PHASE1 Recruiting
NCT07597759 2026-05-19
Phase IIT Trial of SNA009
SmartNuclide Biopharma
Phase EARLY_PHASE1 Completed
NCT07597772 2026-05-19
Preliminary Trial of SNA014 for Pancreatic Cancer
SmartNuclide Biopharma
Phase EARLY_PHASE1 Recruiting
NCT05056896 2026-05-15
ASPIRED-XT: ASPirin Intervention for the REDuction of Colorectal Cancer Risk -EXTension
Massachusetts General Hospital
Phase EARLY_PHASE1 Active not recruiting
NCT07590856 2026-05-15
A Preliminary Efficacy of SNA028 in Patients With Advanced Colorectal Cancer Positive for GPA33
SmartNuclide Biopharma
Phase EARLY_PHASE1 Not yet recruiting
NCT02172651 2026-05-13
Vitamin D in Patients With Stage I-III Colon Cancer or Resectable Colon Cancer Liver Metastases
Dana-Farber Cancer Institute
Phase EARLY_PHASE1 Recruiting
NCT07128355 2026-05-13
Botensilimab, Balstilimab, and SBRT in Colorectal Cancer
Massachusetts General Hospital
Phase EARLY_PHASE1 Recruiting
NCT05086250 2026-05-08
Feasibility Study of Oral Ketamine Versus Placebo for the Treatment of Anxiety in Patients With Pancreatic Cancer
Cedars-Sinai Medical Center
Phase EARLY_PHASE1 Recruiting
NCT06828588 2026-05-08
Pilot Study of [68Ga]Ga-ABY-025 Imaging in Patients Undergoing Treatment With HER2-targeted Therapy
Vanderbilt-Ingram Cancer Center
Phase EARLY_PHASE1 Recruiting
NCT03143270 2026-05-07
A Study to Test the Safety and Feasibility of Nivolumab With Drug Eluting Bead Transarterial Chemoembolization in Patients With Liver Cancer
Memorial Sloan Kettering Cancer Center
Phase EARLY_PHASE1 Active not recruiting
NCT06653010 2026-05-07
Wondercel-UWD1
Wondercel Biotech (ShenZhen)
Phase EARLY_PHASE1 Suspended
NCT06653023 2026-05-07
Wondercel-UWD3
Wondercel Biotech (ShenZhen)
Phase EARLY_PHASE1 Suspended
NCT06675513 2026-05-07
Autologous CAR-T Cells (WD-01) for Metastatic Colorectal Cancer
Wondercel Biotech (ShenZhen)
Phase EARLY_PHASE1 Suspended
NCT04665947 2026-04-29
First-in-human Study of the Theranostic Pair [68Ga]Ga DOTA-5G and [177Lu]Lu DOTA-ABM-5G in Pancreatic Cancer
University of California, Davis
Phase EARLY_PHASE1 Recruiting
NCT06434376 2026-04-28
MRD-positive Colorectal Cancer Patients Combined With Personalized Immune Regulation Diagnosis
Second Affiliated Hospital of Wenzhou Medical University
Phase EARLY_PHASE1 Enrolling by invitation
NCT07553767 2026-04-28
Efficacy and Safety of Pegylated Interferon Alpha-2β in Patients With Hepatitis B-related Hepatocellular Carcinoma After Radical Resection
Ningbo No.2 Hospital
Phase EARLY_PHASE1 Not yet recruiting
NCT00737399 2026-04-27
Anxiety and Depression Levels in Cancer Patients After Self-Application of EFT (Emotional Freedom Techniques)
Soul Medicine Institute
Phase EARLY_PHASE1 Active not recruiting
NCT07389525 2026-04-24
Immune Checkpoint Inhibitor (ICI)-Drug-Drug Interaction (DDI) Study
Indiana University
Phase EARLY_PHASE1 Not yet recruiting
NCT07487402 2026-04-21
Safety and Efficacy of Metabolically Armed GPC3 CAR-T Cells Injection (Meta10-GPC3) in Patients With Unresectable Recurrent/Metastatic Hepatocellular Carcinoma
Zhejiang University
Phase EARLY_PHASE1 Not yet recruiting
NCT03832985 2026-04-09
Pediatric Reporting of Adult-Onset Genomic Results
Geisinger Clinic
Phase EARLY_PHASE1 Completed
NCT06034197 2026-04-08
Fluorescent Probe VGT-309 to ID Cancerous Colorectal Lesions During Augmented Colonoscopy
Stanford University
Phase EARLY_PHASE1 Terminated
NCT07033689 2026-04-03
Feasibility Study of Suizenji, in Patients With Unresectable Pancreatic Ductal Adenocarcinoma (SUNRISE-II)
SONIRE Therapeutics Inc.
Phase EARLY_PHASE1 Recruiting
NCT05108428 2026-04-01
Adaptive Radiation for Locally Advanced Rectal Adenocarcinoma
H. Lee Moffitt Cancer Center and Research Institute
Phase EARLY_PHASE1 Active not recruiting
NCT07089940 2026-03-23
OMO-103 for the Treatment of Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma
OHSU Knight Cancer Institute
Phase EARLY_PHASE1 Recruiting
NCT07486492 2026-03-20
Using Healthy Gut Bacteria to Boost Immune Treatment for Advanced Bowel Cancer
The First Affiliated Hospital of Xiamen University
Phase EARLY_PHASE1 Not yet recruiting
NCT04862260 2026-03-19
Cholesterol Disruption in Combination With the Standard of Care in Patients With Advanced Pancreatic Adenocarcinoma
CHU de Quebec-Universite Laval
Phase EARLY_PHASE1 Active not recruiting
NCT07172282 2026-03-19
INFINITIVE: ImmuNotherapy For PatIeNts wIth colorecTal LIVer MEtastases
Northwell Health
Phase EARLY_PHASE1 Recruiting
NCT06378398 2026-03-13
A Trial of Omeprazole and Low Dose Aspirin to Identify Colorectal Biomarkers of Preventive Efficacy
University of Michigan Rogel Cancer Center
Phase EARLY_PHASE1 Completed
NCT06011772 2026-03-11
EGF-Depleting Therapy CIMAvax-EGF in Combination With Standard Therapy for RAS- and BRAF Wild-Type Metastatic Colorectal Cancer
Roswell Park Cancer Institute
Phase EARLY_PHASE1 Active not recruiting
NCT07254091 2026-03-06
Pilot Study of an Implantable Microdevice for In Situ Evaluation of Drug Response in Patients With Pancreatic Cancer
Northwell Health
Phase EARLY_PHASE1 Recruiting
NCT07446257 2026-03-03
THIO and Cadonilimab in Resectable Hepatocellular Carcinoma
University of Texas Southwestern Medical Center
Phase EARLY_PHASE1 Not yet recruiting
NCT03164486 2026-02-27
First-in-Human Positron Emission Tomography Study Using the 18F-αvβ6-Binding-Peptide
University of California, Davis
Phase EARLY_PHASE1 Active not recruiting
NCT04005690 2026-02-27
Targeted Pathway Inhibition in Patients With Pancreatic Cancer
OHSU Knight Cancer Institute
Phase EARLY_PHASE1 Recruiting
NCT06511037 2026-02-27
PhI Pilot Study Pafolacianine Inject for Intraoperative Imaging on Outcomes of GI Cancer Peritoneal Carcinomatosis
University of California, Irvine
Phase EARLY_PHASE1 Recruiting
NCT07193862 2026-02-27
Pilot Study of an Implantable Microdevice for In Situ Evaluation of Drug Response in Patients With Colorectal Liver Metastasis
Northwell Health
Phase EARLY_PHASE1 Recruiting
NCT07318389 2026-02-27
ASCEND-CRC: Profiling and Targeting Dynamic Tumor Resistance in Patients With Metastatic Colorectal Cancer
M.D. Anderson Cancer Center
Phase EARLY_PHASE1 Not yet recruiting
NCT07420010 2026-02-19
An Open-label, Single-arm Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Profile, and Preliminary Efficacy of KT032 Cell Injection in Patients With Mesothelin-positive Advanced Solid Tumors.
Zhejiang University
Phase EARLY_PHASE1 Not yet recruiting
NCT07416240 2026-02-18
Exploratory Clinical Study of Claudin18.2-Targeted Activated DC and CAR-T Therapy in Advanced Pancreatic Cancer.
Hainan Cancer Hospital
Phase EARLY_PHASE1 Recruiting
NCT06475664 2026-02-12
Colorectal Cancer Legal and Administrative Burden Support: A Pilot Clinical Trial
University of Minnesota
Phase EARLY_PHASE1 Completed
NCT06323291 2026-02-09
Cancer Coaching and Remote Education for Self-Empowerment (CARES) Study
H. Lee Moffitt Cancer Center and Research Institute
Phase EARLY_PHASE1 Completed
NCT02724202 2026-02-06
Curcumin in Combination With 5FU for Colon Cancer
Baylor Research Institute
Phase EARLY_PHASE1 Terminated
NCT07394205 2026-02-06
Clinical Study of CBG131 CAR-T Cell Injection for the Treatment of CLDN18.2-Positive Advanced Gastric and Pancreatic Cancer
First Affiliated Hospital of Wenzhou Medical University
Phase EARLY_PHASE1 Not yet recruiting
NCT07236177 2026-02-05
B-GLUCANCER2
Poitiers University Hospital
Phase EARLY_PHASE1 Recruiting
NCT06824363 2026-01-30
ProofPrincip IntraTu TCells SinglDoseImmunCheckpoinInhib Gastro-Esophage Adenocarcinoma w/ARID1a Mu
University of California, Irvine
Phase EARLY_PHASE1 Not yet recruiting
NCT07378436 2026-01-30
A Clinical Study of GK02 in Malignant Ascites
Beijing Geekgene Technology Co., LTD
Phase EARLY_PHASE1 Recruiting
NCT07371247 2026-01-27
Based on ctDNA-MRD Guided Adjuvant Treatment Escalation After Definitive Chemoradiotherapy for Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma: a Study on Safety and Efficacy
The First Affiliated Hospital with Nanjing Medical University
Phase EARLY_PHASE1 Enrolling by invitation